Medical Manufacturing & Outsourcing - May 2026
'Make or break' material choices for miniaturized medical devices…new 3D printing technique for tissue engineering…rethinking contract manufacturing for a new era. Read all about it in this compendium of articles from the editors of Medical Design Briefs magazine.
Don't have an account?
Overview
The May 2026 Medical Manufacturing & Outsourcing Special Report explores cutting-edge developments, challenges, and strategies in medical device manufacturing, with a strong focus on miniaturization, advanced materials, additive manufacturing, and contract manufacturing adaptability.
A key theme is the critical impact of material choices on manufacturability and reliability in modern miniaturized medical devices. Legacy electronics materials often fail due to shrinkage, thermal mismatches, or biocompatibility issues when applied to today's flexible, integrated, and bio-exposed devices. The report emphasizes early collaboration with manufacturing partners to select adhesives, substrates, and coatings that ensure production scalability, consistent yield, and long-term device performance.
Additive manufacturing (3D printing) gains notable attention for its growing role in medical component production. Examples include the RenAM 500Q system enabling high-volume metal part manufacturing for Permedica, and advanced predictive methods from the University of Maine that integrate computer modeling and experiments to design stronger, lighter 3D printed parts with gyroid infill structures. The report also highlights NASA’s innovative biologically derived materials constructed via engineered cells depositing proteins and metals in 3D patterns, offering new biomaterial production methods.
Significant innovations in biofabrication are featured, notably Missouri University of Science and Technology’s novel light-based 3D printing method for tissue engineering. This approach uses a self-assembling resin to create sacrificial microchannels efficiently, streamlining the fabrication of organs-on-a-chip which simulate human tissue responses for drug testing without animal use.
On the contract manufacturing front, the report presents insights from industry leaders like MICRO’s Brian Semcer on strategies to future-proof medical manufacturing. Emphasis is placed on integrating automation and artificial intelligence for improved repeatability, quality control, and compliance. Workforce development, supply chain resilience through strong supplier partnerships, and embedding quality from design through production rounds out modern best practices.
Other technical briefs discuss the fusion of CAM software with additive processes to boost efficiency and precision in medical manufacturing, and how material physics influence yield in assembly.
Overall, this report paints a forward-looking picture of medical manufacturing evolving through advanced materials science, precision additive manufacturing, biofabrication innovations, and strategic contract manufacturing adaptations to deliver next-generation medical devices and therapies at scale.
